Expression of platelet derived growth factor B chain and β receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: An immunohistochemical study

Heart

Volumn 75, Issue 6, 1996, Pages 549-556

  Tanizawa, Shinichi ^a   Ueda, Makiko ^b   Van Der Loos, Chris M ^a   Van Der Wal, Allard C ^a   Becker, Anton E ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Growth factor; Macrophages; Restenosis; Smooth muscle cells

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B;

ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029900463     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.6.549     Document Type: Article

References (29)

1. Essed CE, van den Brand M, Becker AE. Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration. Br Heart J 1983;49:393-6.
2. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation 1991; 83:1327-32.
3. Wanibuchi H, Ueda M, Dingemans KP, Becker AE. The response to percutaneous transluminal coronary angioplasty: an ultrastructural study of smooth muscle cells and endothelial cells. Cardiovasc Pathol 1992;1:295-306.
4. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990;111:2149-58.
5. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-32.
6. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992;89: 507-11.
7. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb 1993;13:1218-26.
8. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988;82:1134-43.
9. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990; 248:1009-12.
10. Katsuda S, Coltrera MD, Ross R, Gown AM. Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol 993;142:1787-93.
11. Van der Wal AC, Becker AE, van der Loos CM, Tigges AJ, Das PK. Fibrous and lipid-rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept. Coron Artery Dis 1994;5:463-9.
12. Colavita PG, Ideker RE, Reimer KA, Hackel DB, Stack RS. The spectrum of pathology associated with percutaneous transluminal coronary angioplasty during acute myocardial infarction. J Am Coll Cardiol 1986;8:855-60.
13. Kohchi K, Takebayashi S, Block PC, Hiroki T, Nobuyoshi M. Arterial changes after percutaneous transluminal coronary angioplasty. Results at autopsy. J Am Coll Cardiol 1987;10:592-9.
14. Ueda M, Becker AE, Fujimoto T, Tsukada T. The early phenomena of restenosis following percutaneous transluminal coronary angioplasty. Eur Heart J 1991;12:937-45.
15. Naruko T, Ueda M, Becker AE, Tojo O, Teragaki M, Takeuchi K, et al. Angiographic-pathologic correlations after elective percutaneous transluminal coronary angioplasty. Circulation 1993;88:1558-68.
16. Rönnstrand L, Terracio L, Claesson-Welsh L, Heldin CH, Rubin K. Characterization of two monoclonal antibodies reactive with the external domain of the platelet-derived growth factor receptor. J Biol Chem 1988;263:10429-35.
17. Van der Loos CM, Becker AE, van den Oord JJ. Practical suggestions for successful immunoenzyme double-staining experiments. Histochem J 1993;25:1-13.
18. Ueda M, Becker AE, Naruko T, Kojima A. Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans. Coron Artery Dis 1995;6:71-81.
19. Reuterdahl C, Sundberg C, Rubin K, Funa K, Gerdin B. Tissue localization of β receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans. J Clin Invest 1993;91: 2065-75.
20. Hermansson M, Nistér M, Betsholtz C, Heldin CH, Westermark B, Funa K. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA 1988;85:7748-52.
21. Rubin K, Tingström A, Hansson GK, et al. Induction of B type receptors for platelet-derived growth factor in vascular inflammation: possible implications for developments of vascular proliferative lesions. Lancet 1988;i:1353-6.
22. Reuterdahl C, Tingström A, Terracio L, Funa K, Heldin CH, Rubin K. Characterization of platelet-derived growth factor β-receptor expressing cells in the vasculature of human rheumatoid synovium. Lab Invest 1991;64:321-9.
23. Tingström A, Reuterdahl C, Lindahl P, Heldin CH, Rubin K. Expression of platelet-derived growth factor-β receptors on human fibroblasts: regulation by recombinant platelet-derived growth factor-BB, IL-1, and tumor necrosis factor-α. J Immunol 1992;148:546-54.
24. Smits A, Hermansson M, Nistér M, et al. Rat brain capillary endothelial cells express functional PDGF B-type receptors. Growth Factors 1989;2:1-8.
25. Kraiss LW, Raines EW, Wilcox JN, et al. Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J Clin Invest 1993;92:338-48.
26. Yan X-Q, Brady G, Iscove NW. Platelet-derived growth factor (PDGF) activates primitive hematopoietic precursors (pre-CFCmulti) by up-regulating IL-1 in PDGF receptor-expressing macrophages. J Immunol 1993;150: 2440-8.
27. Ueda M, Becker AE, Fujimoto T. Pathological changes induced by repeated percutaneous transluminal coronary angioplasty. Br Heart J 1987;58:635-43.
28. Gronwald RGK, Seifert RA, Bowen-Pope DF. Differential regulation of expression of two platelet-derived growth factor receptor subunits by transforming growth factor-β. J Biol Chem 1989;264:8120-5.
29. Maresta A, Balducelli M, Cantini L, et al. for the STARC investigators. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Circulation 1994;90:2710-5.